Table 1.
Agent | Target | Cancer prevention effect | References |
---|---|---|---|
Selective estrogen receptor modulators | Estrogen receptor (ER) | Reduce ER-positive breast cancer incidence in high-risk populations | 11-18 |
Aromatase inhibitors | Aromatase | Reduce ER-positive breast cancer incidence in high-risk populations | 16, 19, 20 |
Non-steroidal anti-inflammatory drugs | COX1/COX2 | Reduce the occurrence of several cancers, mainly CRC and less notably stomach and esophageal cancers | 21-25 |
Statins | HMG-CoA reductase | Observational studies showed long term statin use reduces incidences of gastrointestinal cancer | 27-30 |
Metformin | Gluconeogenesis | Observational studies showed metformin use lowers risks of cancer incidence and mortality in diabetic patients | 31-34 |
CRC, colorectal cancer; HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme A.